Back to Search Start Over

1133PDA phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC).

Authors :
Hidalgo, M
Epelbaum, R
Wolpin, B M
Stemmer, S M
Geva, R
Golan, T
Borazanci, E
Borad, M
Pedersen, K S
Park, J O
Source :
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Publication Year :
2018

Subjects

Subjects :
*PEMBROLIZUMAB
*ADENOCARCINOMA

Details

Language :
English
ISSN :
09237534
Volume :
29
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
133286763
Full Text :
https://doi.org/10.1093/annonc/mdy288.006
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details